Does Colcrys (colchicine) cause side effects?
Colcrys (colchicine) is used to treat acute flares of gout. It also is used to treat Familial Mediterranean fever (FMF), a genetic autoinflammatory disorder in adults and children 4 years of age or older.
Common side effects of Colcrys include
Serious side effects of Colcrys include
Drug interactions of Colcrys include drugs that reduce the breakdown and elimination of Colcrys from the body by reducing the activity of enzymes that breakdown Colcrys such as atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, lopinavir/ritonavir, nelfinavir, saquinavir, telithromycin, ritonavir, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice, verapamil, cyclosporine, and ranolazine.
In order to avoid side effects from Colcrys the dose of colchicine should be reduced when it is combined with or used within 14 days of drugs that reduce its elimination. Combining Colcrys with statins, for example atorvastatin, simvastatin, and lovastatin, gemfibrozil, or fenofibrate increases the risk of muscle related adverse effects because these drugs also cause muscle related side effects.
Available data from published literature on Colcrys use in pregnancy over several decades have not identified any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes.
Colcrys passes into breast milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Colcrys and any potential adverse effects on the breastfed child from Colcrys or from the underlying maternal condition.
What are the important side effects of Colcrys (colchicine) ?
The most common side effects of colchicine are dose-related and include:
Colcrys (colchicine) side effects list for healthcare professionals
Prophylaxis Of Gout Flares
- The most commonly reported adverse reaction in clinical trials of colchicine for the prophylaxis of gout was diarrhea.
Treatment Of Gout Flares
- The most common adverse reactions reported in the clinical trial with Colcrys for treatment of gout flares were diarrhea (23%) and pharyngolaryngeal pain (3%).
- Gastrointestinal tract adverse effects are the most frequent side effects in patients initiating Colcrys, usually presenting within 24 hours, and occurring in up to 20% of patients given therapeutic doses.
- Typical symptoms include
- abdominal pain and
- These events should be viewed as dose-limiting if severe, as they can herald the onset of more significant toxicity.
Clinical Trials Experience In Gout
Because clinical studies are conducted under widely varying and controlled conditions, adverse reaction rates observed in clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not predict the rates observed in a broader patient population in clinical practice.
- In a randomized, double-blind, placebo-controlled trial in patients with a gout flare, gastrointestinal adverse reactions occurred in 26% of patients using the recommended dose (1.8 mg over one hour) of Colcrys compared to 77% of patients taking a nonrecommended high dose (4.8 mg over six hours) of colchicine and 20% of patients taking placebo.
- Diarrhea was the most commonly reported drug-related gastrointestinal adverse event.
- As shown in Table 3, diarrhea is associated with Colcrys treatment.
- Diarrhea was more likely to occur in patients taking the high-dose regimen than the low-dose regimen.
- Severe diarrhea occurred in 19% and vomiting occurred in 17% of patients taking the nonrecommended high-dose colchicine regimen but did not occur in the recommended low-dose Colcrys regimen.
Table 3: Number (%) of Patients with at Least One Drug-Related Treatment-Emergent Adverse Event with an Incidence of ≥2% of Patients in Any Treatment Group
|MedDRA System Organ Class MedDRA Preferred Term||Colcrys Dose||Placebo|
|Number of Patients with at Least One Drug-Related TEAE||40 (77)||27 (37)||16 (27)|
|Gastrointestinal Disorders||40 (77)||19 (26)||12 (20)|
|Diarrhea||40 (77)||17 (23)||8 (14)|
|Nausea||9 (17)||3 (4)||3 (5)|
|Abdominal Discomfort||0||0||2 (3)|
|General Disorders and Administration Site Conditions||4 (8)||1 (1)||1 (2)|
|Fatigue||2 (4)||1 (1)||1 (2)|
|Metabolic and Nutrition Disorders||0||3 (4)||2 (3)|
|Gout||0||3 (4)||1 (2)|
|Nervous System Disorders||1 (2)||1 (1.4)||2 (3)|
|Headache||1 (2)||1 (1)||2 (3)|
|Respiratory Thoracic Mediastinal Disorders||1 (2)||2 (3)||0|
|Pharyngolaryngeal Pain||1 (2)||2 (3)||0|
Serious toxic manifestations associated with colchicine include myelosuppression, disseminated intravascular coagulation and injury to cells in the renal, hepatic, circulatory and central nervous systems. These most often occur with excessive accumulation or overdosage.
The following adverse reactions have been identified with colchicine. These have been generally reversible upon temporarily interrupting treatment or lowering the dose of colchicine. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Neurological: sensory motor neuropathy
- Dermatological: alopecia, maculopapular rash, purpura, rash
- Digestive: abdominal cramping, abdominal pain, diarrhea, lactose intolerance, nausea, vomiting
- Hematological: leukopenia, granulocytopenia, thrombocytopenia, pancytopenia, aplastic anemia
- Hepatobiliary: elevated AST, elevated ALT
- Musculoskeletal: myopathy, elevated CPK, myotonia, muscle weakness, muscle pain, rhabdomyolysis
- Reproductive: azoospermia, oligospermia
What drugs interact with Colcrys (colchicine)?
- Colcrys (colchicine) is a substrate of the efflux transporter P-glycoprotein (P-gp). Of the cytochrome P450 enzymes tested, CYP3A4 was mainly involved in the metabolism of colchicine.
- If Colcrys is administered with drugs that inhibit P-gp, most of which also inhibit CYP3A4, increased concentrations of colchicine are likely.
- Fatal drug interactions have been reported.
- Physicians should ensure that patients are suitable candidates for treatment with Colcrys and remain alert for signs and symptoms of toxicities related to increased colchicine exposure as a result of a drug interaction.
- Signs and symptoms of Colcrys toxicity should be evaluated promptly and, if toxicity is suspected, Colcrys should be discontinued immediately.
- Table 4 provides recommendations as a result of other potentially significant drug interactions.
- Table 1 provides recommendations for strong and moderate CYP3A4 inhibitors and P-gp inhibitors.
Table 4: Other Potentially Significant Drug Interactions
|Concomitant Drug Class or Food||Noted or Anticipated Outcome||Clinical Comment|
|HMG-Co A Reductase Inhibitors: atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin||Pharmacokinetic and/or pharmacodynamic interaction: the addition of one drug to a stable longterm regimen of the other has resulted in myopathy and rhabdomyolysis (including a fatality)||Weigh the potential benefits and risks and carefully monitor patients for any signs or symptoms of muscle pain, tenderness, or weakness, particularly during initial therapy; monitoring CPK (creatine phosphokinase) will not necessarily prevent the occurrence of severe myopathy.|
|Other Lipid-Lowering Drugs: fibrates, gemfibrozil|
|Digitalis Glycosides: digoxin||P-gp substrate; rhabdomyolysis has been reported|
Multimedia: Slideshows, Images & Quizzes
Gout Diet: The Best and Worst Foods for Your Menu
Whether you get gout can depend on your diet. Some foods like red meat, alcohol, and high-fructose corn syrup in sodas can raise...
Gout Attack Symptoms, Causes, Treatment, and Diet
Gout attacks (gouty arthritis) are caused by crystals of uric acid deposits. Learn about symptoms, causes, treatments and...
Gout Quiz: What is Gout? Is There a Gout Diet?
Learn what causes those painful crystals to form during a gout flare. Take the Gout Quiz to learn all about this painful...
Picture of Gout
Condition characterized by abnormally elevated levels of uric acid in the blood, recurring attacks of joint inflammation...
Related Disease Conditions
Buildup of uric acid crystals in a joint causes gouty arthritis. Symptoms and signs include joint pain, swelling, heat, and redness, typically of a single joint. Gout may be treated with diet and lifestyle changes, as well as medication.
What Is the Fastest Way to Get Rid of Gout?
Gout is a common and complex type of arthritis that can affect anyone, but it is most commonly observed in men. It’s characterized by sudden flares of joint pain, swelling, redness, and tenderness in the joints, often at the base of the big toe. Gout symptoms may come and go, but there are ways to manage symptoms and prevent flares.
Amyloidosis is a group of diseases resulting from abnormal deposition of certain proteins (amyloids) in various bodily areas. The amyloid proteins may either be deposited in one particular area of the body (localized amyloidosis) or they may be deposited throughout the body (systemic amyloidosis). There are three types of systemic amyloidosis: primary (AL), secondary (AA), and familial (ATTR). Primary amyloidosis is not associated with any other diseases and is considered a disease entity of its own. Secondary amyloidosis occurs as a result of another illness. Familial Mediterranean Fever is a form of familial (inherited) amyloidosis. Amyloidosis treatment involves treating the underlying illness and correcting organ failure.
Best Diet For Gout: What To Eat, What To Avoid
Gout is a type of arthritis causing pain and swelling in the joints. The disease happens when the body has high levels of a substance called uric acid or urate. Foods that may help keep gout in check are fresh fruits and vegetables, low-fat dairy products, whole grains, eggs, oils, flaxseeds, potatoes, rice and nuts.
Pseudogout, a form of arthritis, results when deposits of crystals collect in and around the joints. Symptoms of pseudogout include pain, stiffness, warmth, and joint swelling of the knees, ankles, hips, shoulders, and/or wrists. Treatment for pseudogout aims to decrease inflammation through the use of nonsteroidal anti-inflammatory drugs, ice, and rest.
Scleroderma is an autoimmune disease of the connective tissue. It is characterized by the formation of scar tissue (fibrosis) in the skin and organs of the body, leading to thickness and firmness of involved areas. Scleroderma is also referred to as systemic sclerosis, and the cause is unknown. Treatment of scleroderma is directed toward the individual features that are most troubling to the patient.
What Foods Get Rid of Gout?
A gout diet may help decrease uric acid levels in the blood. A gout diet isn't a cure. But it may lower the risk of recurring gout attacks and slow the progression of joint damage.
What Foods Cause Gout?
What is gout? Learn the signs of gout and what to do if you think you have it.
Treatment & Diagnosis
- Gout FAQs
- Gout & Aspirin
- Scleroderma Elbow Tip Pains
- What Is Intercritical Gout?
- What Is a Scleroderma Sine Scleroderma?
- Does Scleroderma Cause Infertility in Women?
- Can Chronic Gout Cause More Serious Problems?
- Can You Get Gout in Your Back?
- How Ofter Does Methotrexate Cure Scleroderma?
- Can Gout Nodules Be Surgically Removed?
- What Is the Relationship Between GERD and Scleroderma?
- Can Blood Pressure Make Gout Worse?
- Can You Get Gout in Your Small Toe?
- Should You Exercise with Gout Inflammation?
- Are Gout and Aplastic Anemia Related?
- Are There Gout Drugs Other than Indomethacin & Allopurinol?
- Can Gout Cause Aplastic Anemia?
- What Are Foods that Cause Gout to Flare up?
- Does Aspirin Cause Gout?
- Scleroderma Symptoms and Signs
- Gout Symptoms
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.